Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

PositiveID names new CEO

PositiveID, a developer of biological detection systems focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection, has appointed William Caragol as chief executive officer (CEO).

Since May 2007, Caragol served in PositiveID as president and since August 2006 as chief financial officer (CFO).

The company has also appointed Bryan Happas as a senior vice president and CFO in July 2011.

Caragol said he looks forward to lead PositiveID to its next stage of growth and success, and he is confident that Bryan, with the experience and achievements will be an integral component of making those goals a reality.

"Since the formation of PositiveID in late 2009, we have assembled a portfolio of intellectual property, products under development and companies, including our iglucose system for diabetes management, our Easy Check breath glucose detection device, our GlucoChip glucose-sensing microchip, and our MicroFluidic Systems subsidiary," Caragol said.

Former CEO Scott Silverman will remain as chairman.